144 related articles for article (PubMed ID: 8945771)
1. Studies on agents with vasodilator and beta-blocking activities. IV.
Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
[TBL] [Abstract][Full Text] [Related]
2. Studies on agents with vasodilator and beta-blocking activities. II.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
[TBL] [Abstract][Full Text] [Related]
3. Studies on agents with vasodilator and beta-blocking activities. I.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
[TBL] [Abstract][Full Text] [Related]
4. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
[TBL] [Abstract][Full Text] [Related]
5. Studies on agents with vasodilator and beta-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665.
Seki T; Kanada A; Nakao T; Shiraiwa M; Asano H; Miyazawa K; Ishimori T; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):84-96. PubMed ID: 9468640
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
Boucher M; Dubray C; DuchĂȘne-Marullaz P
J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
Steiner JA; Clancy A; Manghani KK; James IM
Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
[TBL] [Abstract][Full Text] [Related]
11. Studies on new beta-adrenergic blocking agents. II. Syntheses and pharmacology of 2-anilinotropone derivatives.
Sato Y; Tanaka T; Kumakura S; Koike H; Oshima T
Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):514-22. PubMed ID: 4153810
[No Abstract] [Full Text] [Related]
12. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, hypotensive and diuretic activities of several 3-hydrazino-5,6-dihydrobenzo[h]cinnolines. Part 10: Pyridazine derivatives.
Ravina E; Fueyo J; Teran C; Cid J; Garcia Mera G; Orallo F; Bardan B
Pharmazie; 1992 Aug; 47(8):574-7. PubMed ID: 1438508
[No Abstract] [Full Text] [Related]
14. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
15. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
Pitcher DW; Curry PV; Trounce JR
Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
[TBL] [Abstract][Full Text] [Related]
16. Selectivity in new -adrenergic blocking agents. (3-Amino-2-hydroxypropoxy)benzamides.
Shtacher G; Erez M; Cohen S
J Med Chem; 1973 May; 16(5):516-9. PubMed ID: 4146253
[No Abstract] [Full Text] [Related]
17. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
Baldwin JJ; Hirschmann R; Lumma PK; Lumma WC; Ponticello GS; Sweet CS; Scriabine A
J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
Roba J; Lambelin G; De Schaepdryver AF
Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):182-90. PubMed ID: 4404933
[No Abstract] [Full Text] [Related]
20. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Baldoli E; Bianchi G; Corsico N; Di Francesco GF
Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]